DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for TCID50 assay are 34

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_0186	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Zika virus	Mex2-81	NA	TCID50 assay	Decrease (80 %)	Approved	28099856
DrugRepV_0187	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Zika virus	Mex2-81	NA	TCID50 assay	Decrease (75 %)	Approved	28099856
DrugRepV_0188	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Zika virus	Mex2-81	NA	TCID50 assay	Decrease (95 %)	Approved	28099856
DrugRepV_0189	Cabozantinib	Antineoplastic and Immunomodulating Agents	Cancer	Zika virus	Mex2-81	NA	TCID50 assay	No significant effect (30 %)	Approved	28099856
DrugRepV_0190	Cabozantinib	Antineoplastic and Immunomodulating Agents	Cancer	Zika virus	Mex2-81	NA	TCID50 assay	Decrease (75 %)	Approved	28099856
DrugRepV_0191	Cabozantinib	Antineoplastic and Immunomodulating Agents	Cancer	Zika virus	Mex2-81	NA	TCID50 assay	No significant effect (0 %)	Approved	28099856
DrugRepV_0192	Nanchangmycin	Antibacterial; Antiviral	NA	Chikungunya virus	Mex2-81	NA	TCID50 assay	Decrease (90 %)	NA	28099856
DrugRepV_0193	Nanchangmycin	Antibacterial; Antiviral	NA	Chikungunya virus	Mex2-81	NA	TCID50 assay	Decrease (95 %)	NA	28099856
DrugRepV_0194	Nanchangmycin	Antibacterial; Antiviral	NA	Chikungunya virus	Mex2-81	NA	TCID50 assay	Decrease (95 %)	NA	28099856
DrugRepV_0195	Tenovin-1	Anticancer	Cancer	Zika virus	Mex2-81	NA	TCID50 assay	No significant effect (40 %)	NA	28099856
DrugRepV_0196	Tenovin-1	Anticancer	Cancer	Zika virus	Mex2-81	NA	TCID50 assay	No significant effect (50 %)	NA	28099856
DrugRepV_0197	Tenovin-1	Anticancer	Cancer	Zika virus	Mex2-81	NA	TCID50 assay	Decrease (75 %)	NA	28099856
DrugRepV_0262	Imatinib	Antineoplastic and Immunomodulating Agents	Leukemia | Myelodysplastic/myeloproliferative disease | Gastrointestinal stromal tumors	Severe acute respiratory syndrome coronavirus	MA15	NA	TCID50 assay	Decrease (>100 Fold)	Approved	27466418
DrugRepV_0263	Imatinib	Antineoplastic and Immunomodulating Agents	Leukemia | Myelodysplastic/myeloproliferative disease | Gastrointestinal stromal tumors	Middle East respiratory syndrome coronavirus	Hu/Jordan-N3/2012	NA	TCID50 assay	Decrease (~20 Fold)	Approved	27466418
DrugRepV_0264	Imatinib	Antineoplastic and Immunomodulating Agents	Leukemia | Myelodysplastic/myeloproliferative disease | Gastrointestinal stromal tumors	Severe acute respiratory syndrome coronavirus	MA15	NA	TCID50 assay	Decrease (>10 Fold)	Approved	27466418
DrugRepV_0265	Imatinib	Antineoplastic and Immunomodulating Agents	Leukemia | Myelodysplastic/myeloproliferative disease | Gastrointestinal stromal tumors	Middle East respiratory syndrome coronavirus	Hu/Jordan-N3/2012	NA	TCID50 assay	Decrease (>100 Fold)	Approved	27466418
DrugRepV_0305	Dinaciclib	Anticancer	Cancer	Influenza virus	A/Mississippi/3/01 wt		TCID50 assay	Decrease (1.5 Log10 virus titer (TCID50/ml))	Investigational	26192013
DrugRepV_0306	Dinaciclib	Anticancer	Cancer	Influenza virus	A/Mississippi/3/01 H275Y		TCID50 assay	Decrease (>1 Log10 virus titer (TCID50/ml))	Investigational	26192013
DrugRepV_0307	Flavopiridol	Anticancer	Esophageal cancer | Leukemia (lymphoid) | Lung cancer | Liver cancer	Influenza virus	A/Mississippi/3/01 wt		TCID50 assay	Decrease (1.5 Log10 virus titer (TCID50/ml))	Experimental, Investigational	26192013
DrugRepV_0308	Flavopiridol	Anticancer	Esophageal cancer | Leukemia (lymphoid) | Lung cancer | Liver cancer	Influenza virus	A/Mississippi/3/01 H275Y		TCID50 assay	Decrease (~1 Log10 virus titer (TCID50/ml))	Experimental, Investigational	26192013
DrugRepV_0309	PIK-75	NA	NA	Influenza virus	A/Mississippi/3/01 wt		TCID50 assay	Decrease (~1 Log10 virus titer (TCID50/ml))	NA	26192013
DrugRepV_0310	PIK-75	NA	NA	Influenza virus	A/Mississippi/3/01 H275Y		TCID50 assay	Decrease (~1 Log10 virus titer (TCID50/ml))	NA	26192013
DrugRepV_0740	Probenecid	Musculo-Skeletal System	Gout	Influenza virus	A/WSN/33		TCID50 assay	Decrease (>3 Log10 TCID50)	Approved, Investigational	23129053
DrugRepV_0741	Probenecid	Musculo-Skeletal System	Gout	Influenza virus	A/New/ Caledonia/20/99		TCID50 assay	Decrease (2 Log10 TCID50)	Approved, Investigational	23129053
DrugRepV_0742	Probenecid	Musculo-Skeletal System	Gout	Influenza virus	A/California/04/09		TCID50 assay	Decrease (>1 Log10 TCID50)	Approved, Investigational	23129053
DrugRepV_5267	25-Hydroxycholesterol	NA	NA	Lassa virus	Josiah	NA	TCID50 assay	Decrease (>1.1 Log)	Experimental	27999160
DrugRepV_5268	25-Hydroxycholesterol	NA	NA	Lassa virus	Josiah	NA	TCID50 assay	Decrease (1.4 Log)	Experimental	27999160
DrugRepV_5269	Favipiravir	Antiviral	Influenza virus	Lassa virus	Josiah	NA	TCID50 assay	Decrease (90 %)	Investigational	26456301
DrugRepV_5270	Favipiravir	Antiviral	Influenza virus	Lassa virus	Josiah	NA	TCID50 assay	Decrease (90 %)	Investigational	26456301
DrugRepV_5420	Losmapimod	NA	Chronic Obstructive Pulmonary Disease	Lassa virus	Josiah	NA	TCID50 assay	Decrease (50 %)	Investigational	30953674
DrugRepV_5506	Anthralin	NA	Psoriasis	Influenza virus	H1N1		TCID50 assay	Decrease (99 %)	Approved	32132985
DrugRepV_5507	Anthralin	NA	Psoriasis	Influenza virus	H1N1		TCID50 assay	Decrease (99 %)	Approved	32132985
DrugRepV_6424	Carbenoxolone disodium	NA	Digestive tract ulcers	Dengue virus	Hawaii		TCID50 assay	Decrease (500 Fold)	Experimental	27155198
DrugRepV_6425	Carbenoxolone disodium	NA	Digestive tract ulcers	Dengue virus	New Guinea C		TCID50 assay	Decrease (2000 Fold)	Experimental	27155198